P. Franck et al. / Tetrahedron 64 (2008) 6030e6037
6037
´
`
5. Tapolcsanyi, P.; Maes, B. U. W.; Monsieurs, K.; Lemiere, G. L. F.; Riedl,
Z.; Hajos, G.; Van den Driessche, B.; Dommisse, R. A.; Matyus, P.
NeH), 8.43 (dd, J¼4.6, 1.4 Hz, 1H, H-2), 7.85 (dd, J¼8.2,
1.4 Hz, 1H, H-4), 7.69 (d, J¼2.6 Hz, 1H, H-9), 7.49 (d, J¼
8.8 Hz, 1H, H-6), 7.36 (dd, J¼8.2, 4.6 Hz, 1H, H-3), 7.16
(dd, J¼8.8, 2.6 Hz, 1H, H-7), 3.88 (s, 3H, OeCH3); dC
(DMSO-d6): 153.4, 141.0, 140.7, 135.3, 133.5, 121.8, 119.9,
117.9, 117.1, 112.5, 101.8, 55.5. Anal. Calcd for C12H10N2O:
C, 72.71; H, 5.08; N, 14.13. Found: C, 72.45; H, 4.88; N, 14.07.
´
´
Tetrahedron 2003, 59, 5919.
´
6. Dajka-Halasz, B.; Monsieurs, K.; Elias, O.; Karolyhazy, L.; Tapolcsanyi,
´
P.; Maes, B. U. W.; Riedl, Z.; Hajos, G.; Dommisse, R. A.; Lemiere,
G. L. F.; Kosmrlj, J.; Matyus, P. Tetrahedron 2004, 60, 2283.
´
´
´
´
´
`
ˇ
´
´
7. (a) Monge Vega, A.; Aldana, I.; Fernandez-Alvarez, E. Eur. J. Med. Chem.
1978, 13, 573; (b) Monge Vega, A.; Aldana, I.; Parrado, P.; Font, M.;
Alvarez, E. F. J. Pharm. Sci. 1982, 71, 1406; (c) Monge, A.; Parrado,
´
P.; Font, M.; Fernandez-Alvarez, E. J. Med. Chem. 1987, 30, 1029; (d)
Monge, A.; Font, M.; Parrado, P.; Fernandez-Alvarez, E. Eur. J. Med.
Chem. 1988, 23, 547; (e) Monge, A.; Aldana, I.; Alvarez, T.; Font, M.;
Santiago, E.; Latre, J. A.; Bermejillo, M. J.; Lopez-Unzu, M. J.; Fernan-
dez-Alvarez, E. J. Med. Chem. 1991, 34, 3023; (f) Monge, A.; Aldana, I.;
Alvarez, T.; Losa, M. J.; Font, M.; Cenarruzabeitia, E.; Lasheras, B.;
Frechilla, D.; Castiella, E.; Fernandez-Alvarez, E. Eur. J. Med. Chem.
1991, 26, 655; (g) Frechilla, D.; Bernedo, E.; Castiella, E.; Lasheras,
B.; Cenarruzabeitia, E.; Monge, A.; Aldana, I.; Alvarez, T.; Losa, M. J.;
Font, M. Eur. J. Pharmacol. 1992, 219, 409; (h) Monge, A.; Aldana, I.;
Losa, M. J.; Font, M.; Cenarruzabeitia, E.; Castiella, E.; Frechilla, D.;
Santiago, E.; Martinez de Irujo, J. J.; Alberdi, E.; Lopez-Unzu, M. J.
Arzneim.-Forsch. 1993, 43, 1175; (i) Frechilla, D.; Castiella, E.; Lasheras,
B.; Cenarruzabeitia, E.; Monge, A.; Aldana, I.; Alvarez, T.; Losa, M. J.;
Font, M. J. Cardiovasc. Pharmacol. 1993, 21, 89; (j) Monge, A.; Navarro,
4.6.4. Ethyl 5H-pyrido[3,2-b]indole-8-carboxylate (18d)
The general procedure was followed using ethyl 4-[(2-chloro-
pyridin-3-yl)amino]benzoate (17d)14 (0.1660 g, 0.6 mmol);
eluent: dichloromethane/ethyl acetate (8:2); yield: 92%; white
solid; mp 220e221 ꢀC; dH (DMSO-d6): 11.89 (br s, 1H, NeH),
8.85 (d, J¼1.7 Hz, 1H, H-9), 8.56 (dd, J¼4.6, 1.4 Hz, 1H, H-2),
8.13 (dd, J¼8.6, 1.7 Hz, 1H, H-7), 7.99 (dd, J¼8.2, 1.4 Hz, 1H,
H-4), 7.67 (d, J¼8.6 Hz, 1H, H-6), 7.48 (dd, J¼8.2, 4.6 Hz, 1H,
H-3), 4.38 (q, 2H, OeCH2), 1.39 (t, 3H, CH3); dC (DMSO-d6):
166.2, 143.0, 142.1, 140.9, 133.7, 128.2, 121.9, 121.2, 121.0,
120.9, 118.8, 111.7, 60.4, 14.2. Anal. Calcd for
C14H12N2O2$1.1H2O: C, 64.65; H, 5.50; N, 10.77. Found: C,
64.90; H, 5.23; N, 10.74.
´
M.-E.; Font, M.; Santiago, E.; Alberdi, E.; Martınez-Irujo, J.-J. Arch.
Pharm. 1995, 328, 689; (k) Matsuo, I.; Takakuwa, T.; Kishii, K.; Harada,
M.; Mitani, M. JP Patent 08113574 A2, 1996.
`
8. (a) Jonckers, T. H. M.; Maes, B. U. W.; Lemiere, G. L. F.; Rombouts, G.;
Pieters, L.; Haemers, A.; Dommisse, R. A. Synlett 2003, 615; (b) Van
Acknowledgements
`
Miert, S.; Jonckers, T.; Cimanga, K.; Maes, L.; Maes, B.; Lemiere, G.;
Dommisse, R.; Vlietinck, A.; Pieters, L. Exp. Parasitol. 2004, 108, 163;
The authors acknowledge the financial support of the FWO-
Flanders (Fund for Scientific Research-Flanders) (project
1.5.088.04), the University of Antwerp (NOI), the Flemish
Government (Impulsfinanciering van de Vlaamse Overheid
voor Strategisch Basisonderzoek PFEU 2003) and the Hungar-
ian Ministry of Health (ETT-508/2006). S.H. thanks the IWT-
Flanders (The Institute for the promotion of Innovation by
Science and Technology in Flanders) and P.F. the BOF UA
(Special Research Fund of the University of Antwerp) for a
scholarship. We would like to thank Koen Smits for his con-
tribution to the preparation of 5-methyl-7H-indolo[2,3-c]qui-
nolin-6(5H)-one.
`
´
(c) Hostyn, S.; Maes, B. U. W.; Pieters, L.; Lemiere, G. L. F.; Matyus,
´
P.; Hajos, G.; Dommisse, R. A. Tetrahedron 2005, 61, 1571; (d) Van
Miert, S.; Hostyn, S.; Maes, B. U. W.; Cimanga, K.; Brun, R.; Kaiser,
´
`
M.; Matyus, P.; Dommisse, R.; Lemiere, G.; Vlietinck, A.; Pieters, L.
J. Nat. Prod. 2005, 68, 674.
9. Harris, J. M.; Padwa, A. Org. Lett. 2003, 5, 4195.
10. See for instance: (a) Grigg, R.; Sridharan, V.; Stevenson, P.; Sukirthalin-
gam, S.; Worakun, T. Tetrahedron 1990, 46, 4003; (b) Comins, D. L.;
Baevsky, M. F.; Hong, H. J. Am. Chem. Soc. 1992, 114, 10971; (c)
Comins, D. L.; Hong, H.; Saha, J. K.; Jianhua, G. J. Org. Chem. 1994,
59, 5120e5121; (d) Comins, D. L.; Nolan, J. M. Org. Lett. 2001, 3, 4255.
11. For examples on site-selective Pd-catalyzed aminations based on chemo-
selective oxidative addition: (a) Jonckers, T. H. M.; Maes, B. U. W.;
`
Lemiere, G. L. F.; Dommisse, R. Tetrahedron 2001, 57, 7027; (b) Loones,
K. T. J.; Maes, B. U. W.; Meyers, C.; Deruytter, J. J. Org. Chem. 2006, 71,
260; (c) Loones, K. T. J.; Maes, B. U. W.; Dommisse, R. A. Tetrahedron
2007, 63, 8954; (d) See Refs. 8a and 8c.
References and notes
12. Sabol, M. R.; Owen, J. M.; Erickson, W. R. Synth. Commun. 2000, 30,
427.
1. Hostyn, S.; Maes, B. U. W.; Van Baelen, G.; Gulevskaya, A.; Meyers, C.;
Smits, K. Tetrahedron 2006, 62, 4676.
13. Iwaki, T.; Yasuhara, A.; Sakamoto, T. J. Chem. Soc., Perkin Trans. 1 1999,
1505.
2. Bedford, R. B.; Betham, M. J. Org. Chem. 2006, 71, 9403.
´
´
`
3. Matyus, P.; Maes, B. U. W.; Riedl, Z.; Hajos, G.; Lemiere, G. L. F.;
´
Tapolcsanyi, P.; Monsieurs, K.; Elias, O.; Dommisse, R. A.; Krajsovszky,
`
14. Maes, B. U. W.; Loones, K. T. J.; Jonckers, T. H. M.; Lemiere, G. L. F.;
´
´
Dommisse, R. A.; Haemers, A. Synlett 2002, 1995. For an extension deal-
ing with the synthesis of pyridin-2,3-diamines see: Kuethe, J. T.; Wong,
A.; Davies, I. W. J. Org. Chem. 2004, 22, 7752.
G. Synlett 2004, 1123.
4. For reviews dealing with or showing examples on the construction of
polycyclic aromatic carbons involving Pd-catalyzed aromatic CeH activa-
´
´
15. Timari, G.; Soos, T.; Hajos, G. Synlett 1997, 1067.
´
´
tion see: (a) Echavarren, A. M.; Gomez-Lor, B.; Gonzalez, J. J.; de Frutos,
´
´
16. Rocca, P.; Marsais, F.; Godard, A.; Queguiner, G. Tetrahedron 1993,
49, 49.
O. Synlett 2003, 585; (b) Alberico, D.; Scott, M. E.; Lautens, M. Chem.
Rev. 2007, 107, 174.